Osteoporosis Drugs Linked To Lower Risk of Premature Death

Osteoporosis drugs linked to lower risk of premature death. New research has found a link between taking osteoporosis drugs and lower mortality risk.

Osteoporosis is a bone disease that causes bone loss. As a result, bones become weak. The condition is more common in women, though it affects many men too.

The Centers for Disease Control and Prevention (CDC) estimates that 24.5% of women and 5.1% of men who are 65 years of age or over have osteoporosis of the femur neck or lumbar spine in the United States.

“It’s a common misconception that osteoporosis affects only women, and many people choose to not take recommended treatments,” study co-author Prof. Jacqueline Center said.

Recently, researchers from the Garvan Institute of Medical Research in Darlinghurst investigated whether Osteoporosis drugs are associated with significantly lower mortality risk.

They published the results in two papers. One in Osteoporosis International in April this year and other in the Journal of Bone and Mineral Research.

During the study, the scientists studied the data of 6,120 participants aged 50 years and over. The participants had enrolled in the Canadian Multicentre Osteoporosis Study. The team found that osteoporosis drugs were associated with a 34% lower risk of premature death.

“For many individuals with osteoporosis, bone health isn’t front-of-mind. We hope our study results will encourage people with osteoporosis or at risk of a fracture to seek treatment — and commit to taking it,” first author Dana Bliuc, Ph.D. said.